{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T22:51:59Z","timestamp":1788821519354,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,28]]},"DOI":"10.7759\/cureus.106020","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T13:36:23Z","timestamp":1774704983000},"source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of the Impact of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) on Long-Term Survival and Morbidity Profile: A Systematic Review of the Peritoneal Carcinomatosis Management"],"prefix":"10.7759","author":[{"given":"Cristian Israel","family":"Sarmiento Bonilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Maldonado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humberto Daniel","family":"Paredes Haro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeus Edrian Daniel Alfonso","family":"Gonz\u00e1lez Mercado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis Agustin A","family":"Dunay Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricio Xavier","family":"Duran S","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbey Octavio","family":"L\u00f3pez Bernal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian Camilo","family":"Romero Amaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Paola","family":"Baena Manotas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-018-0703-0","article-title":"Peritoneal metastases from gastrointestinal cancer","volume":"20","author":"Sugarbaker PH","year":"2018","unstructured":"Sugarbaker PH. Peritoneal metastases from gastrointestinal cancer. Curr Oncol Rep. 2018, 20:62. 10.1007\/s11912-018-0703-0","journal-title":"Curr Oncol Rep"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14024","article-title":"Pharmacoepidemiology: using randomised control trials and observational studies in clinical decision-making","volume":"85","author":"Caparrotta TM","year":"2019","unstructured":"Caparrotta TM, Dear JW, Colhoun HM, Webb DJ. Pharmacoepidemiology: using randomised control trials and observational studies in clinical decision-making. Br J Clin Pharmacol. 2019, 85:1907-24. 10.1111\/bcp.14024","journal-title":"Br J Clin Pharmacol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2078-6891.2015.111","article-title":"Chemotherapy for intraperitoneal use: a review of hyperthermic intraperitoneal chemotherapy and early post-operative intraperitoneal chemotherapy","volume":"7","author":"Goodman MD","year":"2016","unstructured":"Goodman MD, McPartland S, Detelich D, Saif MW. Chemotherapy for intraperitoneal use: a review of hyperthermic intraperitoneal chemotherapy and early post-operative intraperitoneal chemotherapy. J Gastrointest Oncol. 2016, 7:45-57. 10.3978\/j.issn.2078-6891.2015.111","journal-title":"J Gastrointest Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2024.1498529","article-title":"Challenges following CRS and HIPEC surgery in cancer patients with peritoneal metastasis: a comprehensive review of clinical outcomes","volume":"11","author":"Karimi M","year":"2024","unstructured":"Karimi M, Shirsalimi N, Sedighi E. Challenges following CRS and HIPEC surgery in cancer patients with peritoneal metastasis: a comprehensive review of clinical outcomes. Front Surg. 2024, 11:1498529. 10.3389\/fsurg.2024.1498529","journal-title":"Front Surg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/jcm7120567","article-title":"Systematic review of variations in hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal metastasis from colorectal cancer","volume":"7","author":"Yurttas C","year":"2018","unstructured":"Yurttas C, Hoffmann G, Tolios A, et al.. Systematic review of variations in hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal metastasis from colorectal cancer. J Clin Med. 2018, 7:567. 10.3390\/jcm7120567","journal-title":"J Clin Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-015-4962-9","article-title":"The role of Ki-67 and pre-cytoreduction parameters in selecting diffuse malignant peritoneal mesothelioma (DMPM) patients for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"23","author":"Kusamura S","year":"2016","unstructured":"Kusamura S, Torres Mesa PA, Cabras A, Baratti D, Deraco M. The role of Ki-67 and pre-cytoreduction parameters in selecting diffuse malignant peritoneal mesothelioma (DMPM) patients for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol. 2016, 23:1468-73. 10.1245\/s10434-015-4962-9","journal-title":"Ann Surg Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2021.0580","article-title":"Hyperthermic intraperitoneal chemotherapy for ovarian and colorectal cancer: a review","volume":"7","author":"van Stein RM","year":"2021","unstructured":"van Stein RM, Aalbers AG, Sonke GS, van Driel WJ. Hyperthermic intraperitoneal chemotherapy for ovarian and colorectal cancer: a review. JAMA Oncol. 2021, 7:1231-8. 10.1001\/jamaoncol.2021.0580","journal-title":"JAMA Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2022.100586","article-title":"Hyperthermic intraperitoneal chemotherapy (HIPEC) for the management of primary advanced and recurrent ovarian cancer: a systematic review and meta-analysis of randomized trials","volume":"7","author":"Filis P","year":"2022","unstructured":"Filis P, Mauri D, Markozannes G, Tolia M, Filis N, Tsilidis K. Hyperthermic intraperitoneal chemotherapy (HIPEC) for the management of primary advanced and recurrent ovarian cancer: a systematic review and meta-analysis of randomized trials. ESMO Open. 2022, 7:100586. 10.1016\/j.esmoop.2022.100586","journal-title":"ESMO Open"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2020.04.018","article-title":"Long-term survival after hyperthermic intraperitoneal chemotherapy using mitomycin C or oxaliplatin in colorectal cancer patients with synchronous peritoneal metastases: a nationwide comparative study","volume":"46","author":"Bakkers C","year":"2020","unstructured":"Bakkers C, van Erning FN, Rovers KP, et al.. Long-term survival after hyperthermic intraperitoneal chemotherapy using mitomycin C or oxaliplatin in colorectal cancer patients with synchronous peritoneal metastases: a nationwide comparative study. Eur J Surg Oncol. 2020, 46:1902-7. 10.1016\/j.ejso.2020.04.018","journal-title":"Eur J Surg Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2020.10.006","article-title":"Long term survival in patients with peritoneal metastasised gastric cancer treated with cytoreductive surgery and HIPEC: a multi-institutional cohort from PSOGI","volume":"47","author":"Brandl A","year":"2021","unstructured":"Brandl A, Yonemura Y, Glehen O, Sugarbaker P, Rau B. Long term survival in patients with peritoneal metastasised gastric cancer treated with cytoreductive surgery and HIPEC: a multi-institutional cohort from PSOGI. Eur J Surg Oncol. 2021, 47:172-80. 10.1016\/j.ejso.2020.10.006","journal-title":"Eur J Surg Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/02656736.2018.1518544","article-title":"Long-term survival in patients with epithelial ovarian cancer following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"35","author":"Le Saux O","year":"2018","unstructured":"Le Saux O, Decullier E, Freyer G, Glehen O, Bakrin N. Long-term survival in patients with epithelial ovarian cancer following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Int J Hyperthermia. 2018, 35:652-7. 10.1080\/02656736.2018.1518544","journal-title":"Int J Hyperthermia"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/10732748241284535","article-title":"A retrospective observational study of hyperthermic intraperitoneal chemotherapy for gastric cancer and colorectal cancer from a single center in the recent 5 years","volume":"31","author":"He M","year":"2024","unstructured":"He M, Li XD, Wang ZW, Sun H, Fan J. A retrospective observational study of hyperthermic intraperitoneal chemotherapy for gastric cancer and colorectal cancer from a single center in the recent 5 years. Cancer Control. 2024, 31:10732748241284535. 10.1177\/10732748241284535","journal-title":"Cancer Control"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-019-1618-4","article-title":"Peritoneal carcinomatosis index predicts survival in colorectal patients undergoing HIPEC using oxaliplatin: a retrospective single-arm cohort study","volume":"17","author":"Burnett A","year":"2019","unstructured":"Burnett A, Lecompte MA, Trabulsi N, et al.. Peritoneal carcinomatosis index predicts survival in colorectal patients undergoing HIPEC using oxaliplatin: a retrospective single-arm cohort study. World J Surg Oncol. 2019, 17:83. 10.1186\/s12957-019-1618-4","journal-title":"World J Surg Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0250726","article-title":"Women survive longer than men undergoing cytoreductive surgery and HIPEC for appendiceal cancer","volume":"16","author":"Rozich NS","year":"2021","unstructured":"Rozich NS, Lewis SE, Chen S, et al.. Women survive longer than men undergoing cytoreductive surgery and HIPEC for appendiceal cancer. PLoS One. 2021, 16:e0250726. 10.1371\/journal.pone.0250726","journal-title":"PLoS One"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-023-14145-4","article-title":"Patterns of recurrence in appendix cancer after complete cytoreduction and hyperthermic intraperitoneal chemotherapy","volume":"30","author":"Nikiforchin A","year":"2023","unstructured":"Nikiforchin A, Sardi A, King MC, et al.. Patterns of recurrence in appendix cancer after complete cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2023, 30:7848-57. 10.1245\/s10434-023-14145-4","journal-title":"Ann Surg Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-022-12761-0","article-title":"Cytoreduction and HIPEC for gastric carcinomatosis: multi-institutional analysis of two phase II clinical trials","volume":"30","author":"Green BL","year":"2023","unstructured":"Green BL, Blumenthaler AN, Gamble LA, et al.. Cytoreduction and HIPEC for gastric carcinomatosis: multi-institutional analysis of two phase II clinical trials. Ann Surg Oncol. 2023, 30:1852-60. 10.1245\/s10434-022-12761-0","journal-title":"Ann Surg Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-023-13932-3","article-title":"The 2022 PSOGI international consensus on HIPEC regimens for peritoneal malignancies: epithelial ovarian cancer","volume":"30","author":"Bhatt A","year":"2023","unstructured":"Bhatt A, Glehen O, Zivanovic O, Brennan D, Nadeau C, Van Driel W, Bakrin N. The 2022 PSOGI international consensus on HIPEC regimens for peritoneal malignancies: epithelial ovarian cancer. Ann Surg Oncol. 2023, 30:8115-37. 10.1245\/s10434-023-13932-3","journal-title":"Ann Surg Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1515\/pp-2021-0152","article-title":"Update of randomized controlled trials evaluating cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in prevention and therapy of peritoneal metastasis: a systematic review","volume":"7","author":"Noiret B","year":"2022","unstructured":"Noiret B, Piessen G, Eveno C. Update of randomized controlled trials evaluating cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in prevention and therapy of peritoneal metastasis: a systematic review. Pleura Peritoneum. 2022, 7:51-61. 10.1515\/pp-2021-0152","journal-title":"Pleura Peritoneum"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1515\/iss-2023-0055","article-title":"Current clinical practices of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"9","author":"Acs M","year":"2024","unstructured":"Acs M, Babucke M, Jusufi M, et al.. Current clinical practices of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Innov Surg Sci. 2024, 9:3-15. 10.1515\/iss-2023-0055","journal-title":"Innov Surg Sci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14051161","article-title":"Contemporary management of locally advanced and recurrent rectal cancer: views from the PelvEx collaborative","volume":"14","author":"PelvEx Collaborative","year":"2022","unstructured":"PelvEx Collaborative. Contemporary management of locally advanced and recurrent rectal cancer: views from the PelvEx collaborative. Cancers (Basel). 2022, 14:1161. 10.3390\/cancers14051161","journal-title":"Cancers (Basel)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-021-02145-1","article-title":"Thirty-three long-term survivors after cytoreductive surgery in patients with peritoneal metastases from colorectal cancer: a retrospective descriptive study","volume":"19","author":"Kamada Y","year":"2021","unstructured":"Kamada Y, Hida K, Ishibashi H, et al.. Thirty-three long-term survivors after cytoreductive surgery in patients with peritoneal metastases from colorectal cancer: a retrospective descriptive study. World J Surg Oncol. 2021, 19:31. 10.1186\/s12957-021-02145-1","journal-title":"World J Surg Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15235641","article-title":"Peritoneal metastasis: a dilemma and challenge in the treatment of metastatic colorectal cancer","volume":"15","author":"Xia W","year":"2023","unstructured":"Xia W, Geng Y, Hu W. Peritoneal metastasis: a dilemma and challenge in the treatment of metastatic colorectal cancer. Cancers (Basel). 2023, 15:5641. 10.3390\/cancers15235641","journal-title":"Cancers (Basel)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2020.02.012","article-title":"Appendiceal tumours and pseudomyxoma peritonei: literature review with PSOGI\/EURACAN clinical practice guidelines for diagnosis and treatment","volume":"47","author":"Govaerts K","year":"2021","unstructured":"Govaerts K, Lurvink RJ, De Hingh IH, et al.. Appendiceal tumours and pseudomyxoma peritonei: literature review with PSOGI\/EURACAN clinical practice guidelines for diagnosis and treatment. Eur J Surg Oncol. 2021, 47:11-35. 10.1016\/j.ejso.2020.02.012","journal-title":"Eur J Surg Oncol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.21147\/j.issn.1000-9604.2020.06.12","article-title":"Hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis: a multicenter propensity score-matched cohort study","volume":"32","author":"Lei Z","year":"2020","unstructured":"Lei Z, Wang J, Li Z, et al.. Hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis: a multicenter propensity score-matched cohort study. Chin J Cancer Res. 2020, 32:794-803. 10.21147\/j.issn.1000-9604.2020.06.12","journal-title":"Chin J Cancer Res"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.5603\/AIT.a2017.0064","article-title":"Perioperative gastrointestinal problems in the ICU","volume":"50","author":"Reintam Blaser A","year":"2018","unstructured":"Reintam Blaser A, Starkopf J, Moonen PJ, Malbrain ML, Oudemans-van Straaten HM. Perioperative gastrointestinal problems in the ICU. Anaesthesiol Intensive Ther. 2018, 50:59-71. 10.5603\/AIT.a2017.0064","journal-title":"Anaesthesiol Intensive Ther"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21749","article-title":"The contemporary management of peritoneal metastasis: a journey from the cold past of treatment futility to a warm present and a bright future","volume":"73","author":"Foster JM","year":"2023","unstructured":"Foster JM, Zhang C, Rehman S, Sharma P, Alexander HR. The contemporary management of peritoneal metastasis: a journey from the cold past of treatment futility to a warm present and a bright future. CA Cancer J Clin. 2023, 73:49-71. 10.3322\/caac.21749","journal-title":"CA Cancer J Clin"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13144015","article-title":"Nutritional status and post-cardiac surgery outcomes: an updated review with emphasis on cognitive function","volume":"13","author":"Juliana N","year":"2024","unstructured":"Juliana N, Abd Aziz NA, Maluin SM, et al.. Nutritional status and post-cardiac surgery outcomes: an updated review with emphasis on cognitive function. J Clin Med. 2024, 13:4015. 10.3390\/jcm13144015","journal-title":"J Clin Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-48126-1_10","article-title":"Post-operative management","author":"Pioli G","year":"2021","unstructured":"Pioli G, Bendini C, Pignedoli P. Post-operative management. Orthogeriatrics: The Management of Older Patients With Fragility Fractures. Falaschi P, Marsh D (ed): Springer, Cham; 2021. 155-80. 10.1007\/978-3-030-48126-1_10"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/anae.14869","article-title":"Postoperative recovery: the importance of the team","volume":"75 Suppl 1","author":"Nilsson U","year":"2020","unstructured":"Nilsson U, Gruen R, Myles PS. Postoperative recovery: the importance of the team. Anaesthesia. 2020, 75 Suppl 1:e158-64. 10.1111\/anae.14869","journal-title":"Anaesthesia"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1002\/jso.24813","article-title":"Clinical studies in CRS and HIPEC: trials, tribulations, and future directions-a systematic review","volume":"117","author":"Morano WF","year":"2018","unstructured":"Morano WF, Khalili M, Chi DS, Bowne WB, Esquivel J. Clinical studies in CRS and HIPEC: trials, tribulations, and future directions-a systematic review. J Surg Oncol. 2018, 117:245-59. 10.1002\/jso.24813","journal-title":"J Surg Oncol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31288-5","article-title":"Gastric cancer","volume":"396","author":"Smyth EC","year":"2020","unstructured":"Smyth EC, Nilsson M, Grabsch HI, et al.. Gastric cancer. Lancet. 2020, 396:635-48. 10.1016\/S0140-6736(20)31288-5","journal-title":"Lancet"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11081164","article-title":"Evolving clinical utility of liquid biopsy in gastrointestinal cancers","volume":"11","author":"Jacobson RA","year":"2019","unstructured":"Jacobson RA, Munding E, Hayden DM, Levy M, Kuzel TM, Pappas SG, Masood A. Evolving clinical utility of liquid biopsy in gastrointestinal cancers. Cancers (Basel). 2019, 11:1164. 10.3390\/cancers11081164","journal-title":"Cancers (Basel)"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.2240","article-title":"Use of machine learning to develop and evaluate models using preoperative and intraoperative data to identify risks of postoperative complications","volume":"4","author":"Xue B","year":"2021","unstructured":"Xue B, Li D, Lu C, et al.. Use of machine learning to develop and evaluate models using preoperative and intraoperative data to identify risks of postoperative complications. JAMA Netw Open. 2021, 4:e212240. 10.1001\/jamanetworkopen.2021.2240","journal-title":"JAMA Netw Open"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v8.i1.67","article-title":"Multimodality treatment strategies have changed prognosis of peritoneal metastases","volume":"8","author":"Lungoci C","year":"2016","unstructured":"Lungoci C, Mironiuc AI, Muntean V, Oniu T, Leebmann H, Mayr M, Piso P. Multimodality treatment strategies have changed prognosis of peritoneal metastases. World J Gastrointest Oncol. 2016, 8:67-82. 10.4251\/wjgo.v8.i1.67","journal-title":"World J Gastrointest Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/465883-evaluation-of-the-impact-of-cytoreductive-surgery-and-hyperthermic-intraperitoneal-chemotherapy-hipec-on-long-term-survival-and-morbidity-profile-a-systematic-review-of-the-peritoneal-carcinomatosis-management","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T13:36:25Z","timestamp":1774704985000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/465883-evaluation-of-the-impact-of-cytoreductive-surgery-and-hyperthermic-intraperitoneal-chemotherapy-hipec-on-long-term-survival-and-morbidity-profile-a-systematic-review-of-the-peritoneal-carcinomatosis-management"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":34,"URL":"https:\/\/doi.org\/10.7759\/cureus.106020","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,28]]}}}